ATE250626T1 - Verfahren zur kupplung zwischen einem peptid und mindestens einer weiteren verbindung in lösung und verwendungen davon - Google Patents

Verfahren zur kupplung zwischen einem peptid und mindestens einer weiteren verbindung in lösung und verwendungen davon

Info

Publication number
ATE250626T1
ATE250626T1 AT00958701T AT00958701T ATE250626T1 AT E250626 T1 ATE250626 T1 AT E250626T1 AT 00958701 T AT00958701 T AT 00958701T AT 00958701 T AT00958701 T AT 00958701T AT E250626 T1 ATE250626 T1 AT E250626T1
Authority
AT
Austria
Prior art keywords
peptide
compound
coupling
hydrazinoacetic
concerns
Prior art date
Application number
AT00958701T
Other languages
English (en)
Inventor
Dominique Bonnet
Oleg Melnyk
Helene Gras-Masse
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9910626A external-priority patent/FR2797631B1/fr
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE250626T1 publication Critical patent/ATE250626T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00958701T 1999-08-19 2000-08-18 Verfahren zur kupplung zwischen einem peptid und mindestens einer weiteren verbindung in lösung und verwendungen davon ATE250626T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9910626A FR2797631B1 (fr) 1999-08-19 1999-08-19 Procede de couplage, en phase homogene, entre un peptide et au moins un autre compose et ses applications
FR9915342A FR2797632B1 (fr) 1999-08-19 1999-12-06 Fonctionnalisation d'un peptide par un groupement alpha- hydrazinoacetique
PCT/FR2000/002336 WO2001014408A2 (fr) 1999-08-19 2000-08-18 Procede de couplage, en solution, entre un peptide et au moins un autre compose et ses applications

Publications (1)

Publication Number Publication Date
ATE250626T1 true ATE250626T1 (de) 2003-10-15

Family

ID=26235081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958701T ATE250626T1 (de) 1999-08-19 2000-08-18 Verfahren zur kupplung zwischen einem peptid und mindestens einer weiteren verbindung in lösung und verwendungen davon

Country Status (8)

Country Link
EP (1) EP1206482B1 (de)
JP (1) JP2003516313A (de)
AT (1) ATE250626T1 (de)
AU (1) AU777475B2 (de)
CA (1) CA2382174A1 (de)
DE (1) DE60005534T2 (de)
FR (1) FR2797632B1 (de)
WO (1) WO2001014408A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813794B1 (fr) * 2000-09-08 2003-01-24 Pasteur Institut Procede de couplage, en solution, entre un peptide et un vecteur lipophile et ses applications
FR2837104B1 (fr) * 2002-03-14 2004-08-06 Dev Des Antigenes Combinatoire Utilisation de melange de lipopeptides pour la fabrication de vaccins
CA2629346A1 (en) * 2005-11-11 2007-05-18 Proteogen Bio S.R.L. Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139349A1 (en) * 1992-06-30 1994-01-20 Joseph C. Hogan, Jr. Aminimide-containing molecules and materials as molecular recognition agents

Also Published As

Publication number Publication date
FR2797632B1 (fr) 2003-01-24
FR2797632A1 (fr) 2001-02-23
EP1206482A2 (de) 2002-05-22
DE60005534D1 (de) 2003-10-30
JP2003516313A (ja) 2003-05-13
AU7013900A (en) 2001-03-19
AU777475B2 (en) 2004-10-21
EP1206482B1 (de) 2003-09-24
WO2001014408A2 (fr) 2001-03-01
DE60005534T2 (de) 2004-06-24
WO2001014408A3 (fr) 2001-08-30
CA2382174A1 (fr) 2001-03-01

Similar Documents

Publication Publication Date Title
DK1476541T3 (da) Cytokin (zcytor17-ligand)
DE60042375D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutanal
GT199800085A (es) Sal tartrato de un dipeptido sustituido.
PT975761E (pt) Interferao beta humano recombinante com solubilidade melhorada
DE3586773D1 (de) Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.
EP0885880A3 (de) Sulfonylalkanoylaminohydroxyethylaminosulfamidsäuren verwendbar als retrovirale Proteasehemmer
ATE250626T1 (de) Verfahren zur kupplung zwischen einem peptid und mindestens einer weiteren verbindung in lösung und verwendungen davon
WO2002101003A3 (fr) Preparation stereoselective de l-acides amines cycliques
DE69007599D1 (de) Verfahren zur Racemisierung optisch aktiver Carbonsäureester.
DE60105037D1 (de) Verfahren zur kupplung in lösung zwischen einem peptid und einer lipophilen verbindung, und verwendungen davon
DE60236853D1 (de) Pharmazeutische zusammensetzung aus f(ab) 2- fragmenten von antikörpern und verfahren zu ihrer herstellung
EP1264834A3 (de) Sonde für das Aufspüren von Sphingomyelin
EP1262536A3 (de) Carbodiimidverbindung, enthaltend eine fluroreszente Gruppe und Verfahren zur Herstellung dieser Verbindung
ATE338055T1 (de) Verfahren zur herstellung von gallensäure
DE69204626D1 (de) Verfahren zur Herstellung von Estern aus Aminosäuren.
FR2687667B1 (fr) Esters d'acides carboxyliques d'hydroxyphenylalcanols comme stabilisants.
MX9307695A (es) Composicion acuosa limpiadora acida auto-espesada.
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
PE20001068A1 (es) Produccion de analogos de tripsinogeno recombinante solubles
WO2004052916A3 (en) Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
DE59400709D1 (de) Verfahren zur Herstellung von 3 bis 5 C-Atome aufweisenden alpha,beta-monoethylenisch ungesättigten Aldehyden, Carbonsäuren oder Nitrilen
DE58908961D1 (de) Verfahren zur Isolierung von 2-Keto-polyhydroxy-C6-carbonsäuren, insbesondere von 2-Keto-L-gulonsäure aus wässrigen Fermentationsausträgen.
ATE149354T1 (de) Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse
DE59915086D1 (de) Rekombinante l-n-carbamoylase aus arthrobacter aurescens, verfahren zur herstellung von l-aminosäuren mittels dieser
AU2666000A (en) Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compoundand a polyalkoxylated fatty alcohol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties